Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 2/2022

01-04-2022 | Kidney Transplantation | REVIEW ARTICLE

Cardiac imaging for the assessment of patients being evaluated for kidney transplantation

Authors: Kameel Kassab, MD, Rami Doukky, MD, MSc, MBA, FASNC

Published in: Journal of Nuclear Cardiology | Issue 2/2022

Login to get access

Abstract

Cardiac risk assessment before kidney transplantation has become widely accepted. However, the optimal patient selection and screening tool for cardiac assessment remain controversial. Clinicians face several challenges in this process, including the ever-growing pre-transplant population, aging transplant candidates, increasing prevalence of coronary artery disease, and scarcity of donor organs. Optimizing the cardiovascular risk profile in kidney transplant candidates is necessary to better appropriate limited donor organs and improve patient outcomes. Increasing waiting times from the initial evaluation for transplant candidacy to the actual transplant raises questions regarding re-testing and re-stratification of risk. In this review, we summarize and discuss the current literature on cardiac evaluation prior to kidney transplantation. We also propose simple evidence-based evaluation algorithms for initial and follow-up CAD surveillance in patients being wait-listed for kidney transplantation.
Appendix
Available only for authorised users
Literature
1.
Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2020;75:A6-7.PubMedCrossRef
2.
Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16:496-506.PubMedCrossRef
3.
Administration HRaS. Organ Procurement and Transplant Network Database.
4.
Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012;60:434-80.PubMedCrossRef
5.
Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, et al. OPTN/SRTR 2016 Annual Data Report: kidney. Am J Transplant. 2018;18(Suppl 1):18-113.PubMedPubMedCentralCrossRef
6.
Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis. 2016;23:281-6.PubMedCrossRef
7.
Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol. 2005;16:808-16.PubMedCrossRef
8.
Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010;55(S1-420):A6-7.CrossRef
9.
Hakeem A, Bhatti S, Chang SM. Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC Cardiovasc Imaging. 2014;7:715-28.PubMedCrossRef
10.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-69.PubMedCrossRef
11.
12.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.PubMedCrossRef
13.
Parikh K, Appis A, Doukky R. Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation. J Nucl Cardiol. 2015;22:282-96.PubMedCrossRef
14.
Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats—a stereological study. Kidney Int. 1992;42:1079-85.PubMedCrossRef
15.
El Hangouche N, Doukky R. Use of myocardial perfusion imaging in the assessment of patients undergoing solid organ transplant. In: Hage FG, editor. Myocardial perfusion imaging (MPI): performance, potential risks and outcomes. New York: University at Buffalo; 2018. p. 177-214.
16.
Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173:1181-4.PubMedPubMedCentralCrossRef
17.
Manoushagian S, Meshkov A. Evaluation of solid organ transplant candidates for coronary artery disease. Am J Transplant. 2014;14:2228-34.PubMedCrossRef
18.
Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217-24.PubMedCrossRef
19.
Jeloka TK, Ross H, Smith R, Huang M, Fenton S, Cattran D, et al. Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant. 2007;21:609-14.PubMedCrossRef
20.
Abbud-Filho M, Adams PL, Alberu J, Cardella C, Chapman J, Cochat P et al. A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 2007;83:1-22
21.
The KDIGO Work Group. KDIGO Clinical Practice Guidline on the Evaluation and Management of Candidates for Kidney Transplantation
22.
Poulin MF, Alexander S, Doukky R. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol. 2016;23:202-11.PubMedCrossRef
23.
Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017;24:112-8.PubMedCrossRef
24.
Doukky R, Fughhi I, Campagnoli T, Wassouf M, Kharouta M, Vij A, et al. Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging. J Nucl Cardiol. 2018;25:2058-68.PubMedCrossRef
25.
Doukky R, Olusanya A, Vashistha R, Saini A, Fughhi I, Mansour K, et al. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging. J Nucl Cardiol. 2015;22:700-13.PubMedCrossRef
26.
Golzar Y, Doukky R. Stress SPECT myocardial perfusion imaging in end-stage renal disease. Curr Cardiovasc Imaging Rep 2017;10.
27.
Vij A, Golzar Y, Doukky R. Regadenoson use in chronic kidney disease and end-stage renal disease: a focused review. J Nucl Cardiol. 2018;25:137-49.PubMedCrossRef
28.
Aljaroudi W, Hermann D, Hage F, Heo J, Iskandrian AE. Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol. 2010;105:133-5.PubMedCrossRef
29.
Doukky R, Rangel MO, Wassouf M, Dick R, Alqaid A, Morales Demori R. The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013;20:205-13.PubMedCrossRef
30.
Doukky R, Morales Demori R, Jain S, Kiriakos R, Mwansa V, Calvin JE. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. “The ASSUAGE trial”. J Nucl Cardiol 2012;19:448-57.
31.
Doukky R, Rangel MO, Dick R, Wassouf M, Alqaid A, Margeta B. Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease-the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013;29:1029-37.PubMedCrossRef
32.
Wang LW, Fahim MA, Hayen A, Mitchell RL, Lord SW, Baines LA, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Am J Kidney Dis. 2011;57:476-87.PubMedCrossRef
33.
Chawla D, Rahaby M, Amin AP, Vashistha R, Alyousef T, Martinez HX, et al. Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems. J Nucl Cardiol. 2011;18:281-90.PubMedCrossRef
34.
Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C, et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation. 1990;49:100-3.PubMedCrossRef
35.
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
36.
Radhakrishnan A, Pickup LC, Price AM, Law JP, Edwards NC, Steeds RP, et al. Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy? Heart. 2019;105:1302-9.PubMedCrossRef
37.
Mao J, Karthikeyan V, Poopat C, Song T, Pantelic M, Chattahi J, et al. Coronary computed tomography angiography in dialysis patients undergoing pre-renal transplantation cardiac risk stratification. Cardiol J. 2010;17:349-61.PubMed
38.
de Bie MK, Buiten MS, Gaasbeek A, Boogers MJ, Roos CJ, Schuijf JD, et al. CT coronary angiography is feasible for the assessment of coronary artery disease in chronic dialysis patients, despite high average calcium scores. PLoS One. 2013;8:e67936.PubMedPubMedCentralCrossRef
39.
Winther S, Svensson M, Jorgensen HS, Bouchelouche K, Gormsen LC, Pedersen BB, et al. Diagnostic Performance of Coronary CT Angiography and Myocardial Perfusion Imaging in Kidney Transplantation Candidates. JACC Cardiovasc Imaging. 2015;8:553-62.PubMedCrossRef
40.
Dundon BK, Pisaniello AD, Nelson AJ, Maia M, Teo KS, Worthley SG, et al. Dobutamine stress cardiac MRI for assessment of coronary artery disease prior to kidney transplantation. Am J Kidney Dis. 2015;65:808-9.PubMedCrossRef
41.
42.
43.
44.
Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol. 2003;92:146-51.PubMedCrossRef
45.
Wong CF, Little MA, Vinjamuri S, Hammad A, Harper JM. Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United kingdom. Transplant Proc. 2008;40:1324-8.PubMedCrossRef
46.
Chew CG, Unger S, Shakib S. Value of myocardial perfusion imaging in renal transplant evaluation. Nephrology (Carlton). 2013;18:376-81.CrossRef
47.
Ives CW, AlJaroudi WA, Kumar V, Farag A, Rizk DV, Oparil S, et al. Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes. Eur J Nucl Med Mol Imaging. 2018;45:1998-2008.PubMedCrossRef
48.
Winther S, Svensson M, Jorgensen HS, Rasmussen LD, Holm NR, Gormsen LC, et al. Prognostic Value of Risk Factors, Calcium Score, Coronary CTA, Myocardial Perfusion Imaging, and Invasive Coronary Angiography in Kidney Transplantation Candidates. JACC Cardiovasc Imaging. 2018;11:842-54.PubMedCrossRef
49.
AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016;23:560-9.PubMedCrossRef
50.
AlJaroudi W, Anokwute C, Fughhi I, Campagnoli T, Wassouf M, Vij A, et al. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2017;26(3):814-22.PubMedCrossRef
51.
Gomez J, Fughhi I, Campagnoli T, Ali A, Doukky R. Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017;24:1666-71.PubMedCrossRef
52.
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012;5:1025-34.PubMedPubMedCentralCrossRef
53.
Shah NR, Charytan DM, Murthy VL, Skali Lami H, Veeranna V, Cheezum MK, et al. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016;27:1823-9.PubMedCrossRef
54.
Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, et al. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018;93:501-9.PubMedCrossRef
55.
56.
Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2:846-54.PubMedPubMedCentralCrossRef
57.
Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008;117:1693-700.PubMedPubMedCentralCrossRef
58.
Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007;153:385-91.PubMedCrossRef
59.
Ramphul R, Fernandez M, Firoozi S, Kaski JC, Sharma R, Banerjee D. Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol. BMC Nephrol. 2018;19:2.PubMedPubMedCentralCrossRef
60.
Tita C, Karthikeyan V, Stroe A, Jacobsen G, Ananthasubramaniam K. Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. J Am Soc Echocardiogr. 2008;21:321-6.PubMedCrossRef
61.
Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol. 2003;14:431-9.PubMedCrossRef
62.
Wang LW, Masson P, Turner RM, Lord SW, Baines LA, Craig JC, et al. Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation. 2015;99:731-45.PubMedCrossRef
63.
64.
65.
De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003;42:263-8.PubMedCrossRef
66.
67.
Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant. 2008;8:1673-83.PubMedCrossRef
68.
Raggi P. Pre-renal transplant risk stratification: a perpetual quandary. JACC Cardiovasc Imaging. 2018;11:855-8.PubMedCrossRef
69.
Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet. 1992;340:998-1002.PubMedCrossRef
70.
Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al. Management of coronary disease in patients with advanced kidney disease. N Engl J Med. 2020;382:1608-18.PubMedPubMedCentralCrossRef
71.
Kamran H, Kupferstein E, Sharma N, Singh G, Sowers JR, Whaley-Connell A, et al. Revascularization versus medical management of coronary artery disease in prerenal transplant patients: a meta-analysis. Cardiorenal Med. 2018;8:192-8.PubMedCentralCrossRef
72.
Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007;100:1020-5.PubMedCrossRef
73.
Rakhit DJ, Marwick TH, Armstrong KA, Johnson DW, Leano R, Isbel NM. Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart. 2006;92:1402-8.PubMedPubMedCentralCrossRef
74.
Tottleben J, Rofael M, Co ML, Vij A, Anokwute C, Campagnoli T, et al. The prognostic value of serial stress myocardial perfusion imaging in asymptomatic end stage renal disease patients awaiting kidney transplant [Abstract]. J Nucl Cardiol. 2018;25:1478.
75.
K. DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-153.
76.
Boudreau RJ, Strony JT, duCret RP, Kuni CC, Wang Y, Wilson RF, et al. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology. 1990;175:103-5.PubMedCrossRef
77.
Vandenberg BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezai K. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation. 1996;62:1230-5.PubMedCrossRef
78.
Garcia Canton C, Culegras C, Hernandez Briz MJ, Palomar R, Moreno A, Toledo A, Esparza N, Suria S, Rossique P, Nieto V, Checa MD. Dobutamine stress echocardiography and stress 99M-technetium methoxyisobutylisonitrile SPECT in the assessment of coronary artery disease in kidney transplant candidates. J Am Soc Nephrol. 1998;9:708A.
79.
Worthley MI, Unger SA, Mathew TH, Russ GR, Horowitz JD. Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. Am J Cardiol. 2003;92:1318-20.PubMedCrossRef
80.
Gowdak LH DPF, De Oliveira AL, Arantes RL, Cesar LA, Ramires JA, et al. Non-invasive screening for coronary artery disease in renal transplant candidates with diabetes is influenced by gender. European Society of Cardiology 2010; European Society of Cardiology Congress.
81.
Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis. 1999;33:1080-90.PubMedCrossRef
82.
West JC, Napoliello DA, Costello JM, Nassef LA, Butcher RJ, Hartle JE, et al. Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transpl Int. 2000;13(Suppl 1):S27-30.PubMedCrossRef
83.
Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20:2207-14.PubMedCrossRef
84.
Ferreira PA, de Lima VC, Campos Filho O, Gil MA, Cordovil A, Machado CV, et al. Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates. Arq Bras Cardiol. 2007;88:45-51.PubMedCrossRef
85.
Gang S, Dabhi M, Rajapurkar MM. Ischaemia imaging in type 2 diabetic kidney transplant candidates—is coronary angiography essential? Nephrol Dial Transplant. 2007;22:2334-8.PubMedCrossRef
86.
Sharma R, Mehta RL, Brecker SJ, Gaze DC, Gregson H, Streather CP, et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coron Artery Dis. 2009;20:230-7.PubMedCrossRef
87.
Cai Q, Serrano R, Kalyanasundaram A, Shirani J. A preoperative echocardiographic predictive model for assessment of cardiovascular outcome after renal transplantation. J Am Soc Echocardiogr. 2010;23:560-6.PubMedCrossRef
88.
Iio K, Nagasawa Y, Kimura T, Yamasaki K, Takeda Y, Hamano T, et al. Assessment of coronary stenosis by a 16-slice MDCT scanner in asymptomatic diabetic patients starting dialysis therapy. Nephron Clin Pract. 2008;109:c72-9.PubMedCrossRef
89.
Park MY, Choi SJ, Kim JK, Hwang SD, Suh J, Seo HS, et al. Use of multidetector computed tomography for evaluating coronary artery disease in patients undergoing dialysis. Nephrology (Carlton). 2011;16:285-9.CrossRef
90.
Lewis MS, Wilson RA, Walker KW, Wilson DJ, Norman DJ, Barry JM, et al. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol. 2002;89:847-50.PubMedCrossRef
91.
Atkinson P, Chiu DY, Sharma R, Kalra PR, Ward C, Foley RN, et al. Predictive value of myocardial and coronary imaging in the long-term outcome of potential renal transplant recipients. Int J Cardiol. 2011;146:191-6.PubMedCrossRef
92.
Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol. 2008;102:1451-6.PubMedCrossRef
93.
Delville M, Sabbah L, Girard D, Elie C, Manceau S, Piketty M, et al. Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS One. 2015;10:e0131237.PubMedPubMedCentralCrossRef
Metadata
Title
Cardiac imaging for the assessment of patients being evaluated for kidney transplantation
Authors
Kameel Kassab, MD
Rami Doukky, MD, MSc, MBA, FASNC
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 2/2022
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-021-02561-6

Other articles of this Issue 2/2022

Journal of Nuclear Cardiology 2/2022 Go to the issue

ORIGINAL ARTICLE

Accuracy of PET quantification in [68Ga]Ga-pentixafor PET/MR imaging of carotid plaques

EDITORIAL

Beyond traditional cardiovascular risk factors: Could frailty and other morbidities explain the worse prognosis in patients undergoing pharmacologic stress?

ORIGINAL ARTICLE

Evolution of symptoms in patients with stable angina after normal regadenoson myocardial perfusion imaging: The Radionuclide Imaging and Symptomatic Evolution study (RISE)

EDITORIAL

Editorial: 18F-Fluoride PET/MR in cardiac amyloid; simple addition versus synergy?

ORIGINAL ARTICLE

Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis

ORIGINAL ARTICLE

Activity regimes for 82Rb cardiac PET: Effects on absolute MBF and MPI